Castlight Health Inc (NYSE:CSLT) has been given a consensus recommendation of “Hold” by the ten research firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $5.18.

A number of research firms have recently commented on CSLT. BidaskClub downgraded Castlight Health from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th. Zacks Investment Research upgraded Castlight Health from a “hold” rating to a “buy” rating and set a $4.50 target price for the company in a research note on Monday, October 30th. Canaccord Genuity reiterated a “buy” rating and issued a $7.00 target price on shares of Castlight Health in a research note on Thursday, October 26th. Chardan Capital lowered their target price on Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a research note on Thursday, October 26th. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $5.00 target price on shares of Castlight Health in a research note on Wednesday, October 25th.

Castlight Health (NYSE CSLT) opened at $3.70 on Thursday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.94 and a current ratio of 1.94. Castlight Health has a twelve month low of $3.05 and a twelve month high of $5.50.

Castlight Health (NYSE:CSLT) last released its quarterly earnings data on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.02. The company had revenue of $34.60 million for the quarter, compared to the consensus estimate of $34.61 million. Castlight Health had a negative return on equity of 32.57% and a negative net margin of 45.14%. The company’s quarterly revenue was up 35.7% compared to the same quarter last year. During the same period last year, the business posted ($0.05) EPS. analysts predict that Castlight Health will post -0.43 EPS for the current year.

In other Castlight Health news, CFO Mangini Siobhan Nolan sold 8,866 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $3.70, for a total transaction of $32,804.20. Following the completion of the sale, the chief financial officer now owns 78,561 shares in the company, valued at approximately $290,675.70. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, President Robert Derek Newell acquired 30,000 shares of the stock in a transaction on Friday, October 27th. The shares were acquired at an average price of $3.95 per share, with a total value of $118,500.00. Following the purchase, the president now owns 128,671 shares in the company, valued at $508,250.45. The disclosure for this purchase can be found here. In the last quarter, insiders sold 22,778 shares of company stock valued at $84,411. Insiders own 24.38% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. FMR LLC grew its position in shares of Castlight Health by 49.2% in the 2nd quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock worth $47,451,000 after acquiring an additional 3,768,009 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Castlight Health by 36.0% in the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock worth $15,094,000 after acquiring an additional 963,188 shares in the last quarter. Prudential PLC grew its position in shares of Castlight Health by 23.5% in the 2nd quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock worth $8,311,000 after acquiring an additional 380,920 shares in the last quarter. Gagnon Securities LLC grew its position in shares of Castlight Health by 3.3% in the 3rd quarter. Gagnon Securities LLC now owns 1,484,726 shares of the software maker’s stock worth $6,384,000 after acquiring an additional 47,398 shares in the last quarter. Finally, Maverick Capital Ltd. grew its position in shares of Castlight Health by 2.8% in the 2nd quarter. Maverick Capital Ltd. now owns 1,221,809 shares of the software maker’s stock worth $5,071,000 after acquiring an additional 33,735 shares in the last quarter. Hedge funds and other institutional investors own 42.55% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Castlight Health Inc (CSLT) Receives Average Rating of “Hold” from Brokerages” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/12/07/castlight-health-inc-cslt-receives-average-rating-of-hold-from-brokerages.html.

About Castlight Health

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.